BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18776263)

  • 1. Synthesis and properties of (alpha-P-borano)-nucleoside 5'-triphosphate analogues as potential antiviral agents.
    Cheek MA; Dobrikov MI; Wennefors CK; Xu Z; Hashmi SN; Shen X; Shaw BR
    Nucleic Acids Symp Ser (Oxf); 2008; (52):81-2. PubMed ID: 18776263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and properties of novel triphosphate analogues: ribonucleoside and deoxyribonucleoside (alpha-P-borano, alpha-P-thio)triphosphates.
    Lin J; Porter KW; Shaw BR
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1019-23. PubMed ID: 11562950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro antiviral evaluation, and stability studies of novel alpha-borano-nucleotide analogues of 9-[2-(phosphonomethoxy)ethyl]adenine and (R)-9-[2-(phosphonomethoxy)propyl]adenine.
    Barral K; Priet S; Sire J; Neyts J; Balzarini J; Canard B; Alvarez K
    J Med Chem; 2006 Dec; 49(26):7799-806. PubMed ID: 17181162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 2',3'-dideoxynucleoside 5'-alpha-P-borano-beta,gamma-(difluoromethylene)triphosphates and their inhibition of HIV-1 reverse transcriptase.
    Boyle NA; Rajwanshi VK; Prhavc M; Wang G; Fagan P; Chen F; Ewing GJ; Brooks JL; Hurd T; Leeds JM; Bruice TW; Cook PD
    J Med Chem; 2005 Apr; 48(7):2695-700. PubMed ID: 15801860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-nucleoside inhibitors of the HCV polymerase.
    Sarisky RT
    J Antimicrob Chemother; 2004 Jul; 54(1):14-6. PubMed ID: 15190019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties.
    Olsen DB; Eldrup AB; Bartholomew L; Bhat B; Bosserman MR; Ceccacci A; Colwell LF; Fay JF; Flores OA; Getty KL; Grobler JA; LaFemina RL; Markel EJ; Migliaccio G; Prhavc M; Stahlhut MW; Tomassini JE; MacCoss M; Hazuda DJ; Carroll SS
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3944-53. PubMed ID: 15388457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convenient synthesis of nucleoside borane diphosphate analogues: deoxy- and ribonucleoside 5'-P(alpha)-boranodiphosphates.
    Li P; Shaw BR
    J Org Chem; 2004 Oct; 69(21):7051-7. PubMed ID: 15471452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly efficient, asymmetric synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Fitch DM; Evans KA; Chai D; Duffy KJ
    Org Lett; 2005 Nov; 7(24):5521-4. PubMed ID: 16288546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis C viral RNA-dependent RNA polymerase by α-P-boranophosphate nucleotides: exploring a potential strategy for mechanism-based HCV drug design.
    Cheek MA; Sharaf ML; Dobrikov MI; Shaw BR
    Antiviral Res; 2013 May; 98(2):144-52. PubMed ID: 23466667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate.
    Slater MJ; Amphlett EM; Andrews DM; Bravi G; Burton G; Cheasty AG; Corfield JA; Ellis MR; Fenwick RH; Fernandes S; Guidetti R; Haigh D; Hartley CD; Howes PD; Jackson DL; Jarvest RL; Lovegrove VL; Medhurst KJ; Parry NR; Price H; Shah P; Singh OM; Stocker R; Thommes P; Wilkinson C; Wonacott A
    J Med Chem; 2007 Mar; 50(5):897-900. PubMed ID: 17269759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of AZT 5'-triphosphate mimics and their inhibitory effects on HIV-1 reverse transcriptase.
    Wang G; Boyle N; Chen F; Rajappan V; Fagan P; Brooks JL; Hurd T; Leeds JM; Rajwanshi VK; Jin Y; Prhavc M; Bruice TW; Cook PD
    J Med Chem; 2004 Dec; 47(27):6902-13. PubMed ID: 15615539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
    Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
    J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening.
    Kim J; Kim KS; Kim DE; Chong Y
    Chem Biol Drug Des; 2008 Dec; 72(6):585-91. PubMed ID: 19090925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel 4'-cyclopropyl-5'-norcarbocyclic adenosine phosphonic acid analogues.
    Shen GH; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2010 Nov; 29(11):905-19. PubMed ID: 21128176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
    Randolph JT; Flentge CA; Huang PP; Hutchinson DK; Klein LL; Lim HB; Mondal R; Reisch T; Montgomery DA; Jiang WW; Masse SV; Hernandez LE; Henry RF; Liu Y; Koev G; Kati WM; Stewart KD; Beno DW; Molla A; Kempf DJ
    J Med Chem; 2009 May; 52(10):3174-83. PubMed ID: 19402666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.
    Eldrup AB; Prhavc M; Brooks J; Bhat B; Prakash TP; Song Q; Bera S; Bhat N; Dande P; Cook PD; Bennett CF; Carroll SS; Ball RG; Bosserman M; Burlein C; Colwell LF; Fay JF; Flores OA; Getty K; LaFemina RL; Leone J; MacCoss M; McMasters DR; Tomassini JE; Von Langen D; Wolanski B; Olsen DB
    J Med Chem; 2004 Oct; 47(21):5284-97. PubMed ID: 15456273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors.
    Di Santo R; Fermeglia M; Ferrone M; Paneni MS; Costi R; Artico M; Roux A; Gabriele M; Tardif KD; Siddiqui A; Pricl S
    J Med Chem; 2005 Oct; 48(20):6304-14. PubMed ID: 16190757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antiviral activity of novel 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the novel 3-amino-5-methyl-1-(beta-D-ribofuranosyl)- and 3-amino-5-methyl-1-(2-deoxy-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexaazaacenaphthylene as analogues of triciribine.
    Migawa MT; Drach JC; Townsend LB
    J Med Chem; 2005 Jun; 48(11):3840-51. PubMed ID: 15916436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective synthesis of PSI-352938: a β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyl-3',5'-cyclic phosphate nucleotide prodrug for the treatment of HCV.
    Reddy PG; Chun BK; Zhang HR; Rachakonda S; Ross BS; Sofia MJ
    J Org Chem; 2011 May; 76(10):3782-90. PubMed ID: 21469736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.